547 related articles for article (PubMed ID: 33183404)
1. Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020.
Mehew J; Johnson R; Roberts D; Harvala H
Euro Surveill; 2020 Nov; 25(45):. PubMed ID: 33183404
[TBL] [Abstract][Full Text] [Related]
2. Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020.
Harvala H; Mehew J; Robb ML; Ijaz S; Dicks S; Patel M; Watkins N; Simmonds P; Brooks T; Johnson R; Gopal R; Roberts DJ; Zambon M;
Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700670
[TBL] [Abstract][Full Text] [Related]
3. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.
Zhang L; Pang R; Xue X; Bao J; Ye S; Dai Y; Zheng Y; Fu Q; Hu Z; Yi Y
Aging (Albany NY); 2020 Apr; 12(8):6536-6542. PubMed ID: 32320384
[TBL] [Abstract][Full Text] [Related]
4. The convalescent sera option for containing COVID-19.
Casadevall A; Pirofski LA
J Clin Invest; 2020 Apr; 130(4):1545-1548. PubMed ID: 32167489
[No Abstract] [Full Text] [Related]
5. Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres.
Mehew J; Johnson R; Roberts D; Griffiths A; Harvala H
Transfus Med; 2022 Aug; 32(4):327-337. PubMed ID: 35434868
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
[TBL] [Abstract][Full Text] [Related]
7. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
Farrugia A
Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
[No Abstract] [Full Text] [Related]
8. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
9. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike.
Seghatchian J; Lanza F
Transfus Apher Sci; 2020 Jun; 59(3):102794. PubMed ID: 32448638
[No Abstract] [Full Text] [Related]
10. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
Accorsi P; Berti P; de Angelis V; De Silvestro G; Mascaretti L; Ostuni A;
Transfus Apher Sci; 2020 Aug; 59(4):102817. PubMed ID: 32532691
[TBL] [Abstract][Full Text] [Related]
11. Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19.
Franchini M; Del Fante C; Klersy C; Glingani C; Percivalle E; Baldanti F; Perotti C
Semin Thromb Hemost; 2020 Oct; 46(7):804-806. PubMed ID: 32512588
[No Abstract] [Full Text] [Related]
12. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
Xi Y
Signal Transduct Target Ther; 2020 Sep; 5(1):203. PubMed ID: 32934211
[No Abstract] [Full Text] [Related]
13. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
Bradfute SB; Hurwitz I; Yingling AV; Ye C; Cheng Q; Noonan TP; Raval JS; Sosa NR; Mertz GJ; Perkins DJ; Harkins MS
J Infect Dis; 2020 Oct; 222(10):1620-1628. PubMed ID: 32779705
[TBL] [Abstract][Full Text] [Related]
14. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
Klein SL; Pekosz A; Park HS; Ursin RL; Shapiro JR; Benner SE; Littlefield K; Kumar S; Naik HM; Betenbaugh MJ; Shrestha R; Wu AA; Hughes RM; Burgess I; Caturegli P; Laeyendecker O; Quinn TC; Sullivan D; Shoham S; Redd AD; Bloch EM; Casadevall A; Tobian AA
J Clin Invest; 2020 Nov; 130(11):6141-6150. PubMed ID: 32764200
[TBL] [Abstract][Full Text] [Related]
15. Management of COVID-19 Virus Infection by Convalescent Plasma.
Cheraghali AM; Abolghasemi H; Eshghi P
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
[TBL] [Abstract][Full Text] [Related]
16. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V
J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
[TBL] [Abstract][Full Text] [Related]
18. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population.
Yi Z; Ling Y; Zhang X; Chen J; Hu K; Wang Y; Song W; Ying T; Zhang R; Lu H; Yuan Z
Emerg Microbes Infect; 2020 Dec; 9(1):1988-1996. PubMed ID: 32844713
[No Abstract] [Full Text] [Related]
19. Convalescent Plasma and COVID-19.
Malani AN; Sherbeck JP; Malani PN
JAMA; 2020 Aug; 324(5):524. PubMed ID: 32530454
[No Abstract] [Full Text] [Related]
20. A serological assay to detect SARS-CoV-2 seroconversion in humans.
Amanat F; Stadlbauer D; Strohmeier S; Nguyen THO; Chromikova V; McMahon M; Jiang K; Arunkumar GA; Jurczyszak D; Polanco J; Bermudez-Gonzalez M; Kleiner G; Aydillo T; Miorin L; Fierer DS; Lugo LA; Kojic EM; Stoever J; Liu STH; Cunningham-Rundles C; Felgner PL; Moran T; García-Sastre A; Caplivski D; Cheng AC; Kedzierska K; Vapalahti O; Hepojoki JM; Simon V; Krammer F
Nat Med; 2020 Jul; 26(7):1033-1036. PubMed ID: 32398876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]